These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 9486668
1. Expression of cyclin-dependent kinase inhibitors in vascular disease. Tanner FC, Yang ZY, Duckers E, Gordon D, Nabel GJ, Nabel EG. Circ Res; 1998 Feb 23; 82(3):396-403. PubMed ID: 9486668 [Abstract] [Full Text] [Related]
2. Differential effects of the cyclin-dependent kinase inhibitors p27(Kip1), p21(Cip1), and p16(Ink4) on vascular smooth muscle cell proliferation. Tanner FC, Boehm M, Akyürek LM, San H, Yang ZY, Tashiro J, Nabel GJ, Nabel EG. Circulation; 2000 May 02; 101(17):2022-5. PubMed ID: 10790340 [Abstract] [Full Text] [Related]
3. Concordant upregulation of type II-TGF-beta-receptor, the cyclin-dependent kinases inhibitor P27Kip1 and cyclin E in human atherosclerotic tissue: implications for lesion cellularity. Ihling C, Technau K, Gross V, Schulte-Mönting J, Zeiher AM, Schaefer HE. Atherosclerosis; 1999 May 02; 144(1):7-14. PubMed ID: 10381272 [Abstract] [Full Text] [Related]
4. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. Chen D, Krasinski K, Sylvester A, Chen J, Nisen PD, Andrés V. J Clin Invest; 1997 May 15; 99(10):2334-41. PubMed ID: 9153274 [Abstract] [Full Text] [Related]
5. Liver X receptor agonists suppress vascular smooth muscle cell proliferation and inhibit neointima formation in balloon-injured rat carotid arteries. Blaschke F, Leppanen O, Takata Y, Caglayan E, Liu J, Fishbein MC, Kappert K, Nakayama KI, Collins AR, Fleck E, Hsueh WA, Law RE, Bruemmer D. Circ Res; 2004 Dec 10; 95(12):e110-23. PubMed ID: 15539633 [Abstract] [Full Text] [Related]
6. Adenovirus-mediated overexpression of a cyclin-dependent kinase inhibitor, p57Kip2, suppressed vascular smooth muscle cell proliferation. Takagi Y. Hokkaido Igaku Zasshi; 2002 May 10; 77(3):221-30. PubMed ID: 12056049 [Abstract] [Full Text] [Related]
7. Involvement of p27Kip1 in G1 arrest by high dose 5 alpha-dihydrotestosterone in LNCaP human prostate cancer cells. Tsihlias J, Zhang W, Bhattacharya N, Flanagan M, Klotz L, Slingerland J. Oncogene; 2000 Feb 03; 19(5):670-9. PubMed ID: 10698512 [Abstract] [Full Text] [Related]
8. Local cyclin-dependent kinase inhibition by flavopiridol inhibits coronary artery smooth muscle cell proliferation and migration: Implications for the applicability on drug-eluting stents to prevent neointima formation following vascular injury. Jaschke B, Milz S, Vogeser M, Michaelis C, Vorpahl M, Schömig A, Kastrati A, Wessely R. FASEB J; 2004 Aug 03; 18(11):1285-7. PubMed ID: 15180955 [Abstract] [Full Text] [Related]
9. Mevastatin can cause G1 arrest and induce apoptosis in pulmonary artery smooth muscle cells through a p27Kip1-independent pathway. Fouty BW, Rodman DM. Circ Res; 2003 Mar 21; 92(5):501-9. PubMed ID: 12600884 [Abstract] [Full Text] [Related]
11. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells. Cereseto A, Washington Parks R, Rivadeneira E, Franchini G. Oncogene; 1999 Apr 15; 18(15):2441-50. PubMed ID: 10229195 [Abstract] [Full Text] [Related]
12. TGF-beta mediated G1 arrest in a human melanoma cell line lacking p15INK4B: evidence for cooperation between p21Cip1/WAF1 and p27Kip1. Flørenes VA, Bhattacharya N, Bani MR, Ben-David Y, Kerbel RS, Slingerland JM. Oncogene; 1996 Dec 05; 13(11):2447-57. PubMed ID: 8957087 [Abstract] [Full Text] [Related]
13. Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells. Orend G, Hunter T, Ruoslahti E. Oncogene; 1998 May 05; 16(20):2575-83. PubMed ID: 9632134 [Abstract] [Full Text] [Related]
14. Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1. Bacqueville D, Casagrande F, Perret B, Chap H, Darbon JM, Breton-Douillon M. Biochem Biophys Res Commun; 1998 Mar 27; 244(3):630-6. PubMed ID: 9535716 [Abstract] [Full Text] [Related]
15. Expression of cyclin-dependent kinase inhibitors, p21cip1 and p27kip1, during wound healing in rats. Zhu X, Hu C, Zhang Y, Li L, Wang Z. Wound Repair Regen; 2001 Mar 27; 9(3):205-12. PubMed ID: 11472617 [Abstract] [Full Text] [Related]
16. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Wei GL, Krasinski K, Kearney M, Isner JM, Walsh K, Andrés V. Circ Res; 1997 Mar 27; 80(3):418-26. PubMed ID: 9048663 [Abstract] [Full Text] [Related]
17. CaMK-II inhibition reduces cyclin D1 levels and enhances the association of p27kip1 with Cdk2 to cause G1 arrest in NIH 3T3 cells. Morris TA, DeLorenzo RJ, Tombes RM. Exp Cell Res; 1998 May 01; 240(2):218-27. PubMed ID: 9596994 [Abstract] [Full Text] [Related]
18. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Koyama H, Raines EW, Bornfeldt KE, Roberts JM, Ross R. Cell; 1996 Dec 13; 87(6):1069-78. PubMed ID: 8978611 [Abstract] [Full Text] [Related]
19. Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting regulators of the cell cycle. Gallo R, Padurean A, Jayaraman T, Marx S, Roque M, Adelman S, Chesebro J, Fallon J, Fuster V, Marks A, Badimon JJ. Circulation; 1999 Apr 27; 99(16):2164-70. PubMed ID: 10217658 [Abstract] [Full Text] [Related]